摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-碘吡啶-2-羧酸 | 73841-32-4

中文名称
3-碘吡啶-2-羧酸
中文别名
3-碘吡啶甲酸
英文名称
3-iodopicolinic acid
英文别名
3-iodopyridine-2-carboxylic acid
3-碘吡啶-2-羧酸化学式
CAS
73841-32-4
化学式
C6H4INO2
mdl
——
分子量
249.008
InChiKey
NBPSOUHMLHTKID-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    2-8°C

SDS

SDS:0c0fc1d1790f4807a95a37591b8b7af2
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3-Iodopicolinic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 3-Iodopicolinic acid
CAS number: 73841-32-4

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H4INO2
Molecular weight: 249.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-碘吡啶-2-羧酸氯化亚砜caesium carbonate 、 sodium hydroxide 作用下, 以 N,N-二甲基甲酰胺甲苯 为溶剂, 反应 18.0h, 生成 3-(2,5-dichlorophenoxy)pyrazine-2-carboxylic acid chloride
    参考文献:
    名称:
    杂芳基酰胺类衍生物及其作为TGR5激动剂的应用
    摘要:
    本发明属于医药技术领域,具体涉及式(I)所示的杂芳基酰胺类TGR5激动剂化合物、其药学上可接受的盐、其酯、其立体异构体或前药,其中R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、X1、X2、X3和Y如说明书中所定义;本发明还涉及这些化合物的制备方法、药物制剂、药物组合物以及这些化合物在制备治疗和/或预防与TGR5活性调节有关的疾病中的用途。
    公开号:
    CN106317027A
  • 作为产物:
    描述:
    2-吡啶甲酸2,2,6,6-四甲基哌啶正丁基锂 、 Amberlyst(R) IR-200 作用下, 以 四氢呋喃甲醇正己烷 为溶剂, 反应 0.92h, 生成 3-碘吡啶-2-羧酸
    参考文献:
    名称:
    未保护的吡啶羧酸的直接锂化:卤代衍生物的合成
    摘要:
    所有同分异构的吡啶甲酸锂锂的去质子化反应,然后用六氯乙烷或碘进行捕集,分别直接获得了氯代和碘代吡啶甲酸。从5-溴烟酸锂开始,在C4处引入碘原子并进一步进行卤素迁移,使得该方法的潜力得以扩展至合成更精细的衍生物。
    DOI:
    10.1016/s0040-4020(02)00673-7
点击查看最新优质反应信息

文献信息

  • Piperazine Heteroaryl Derivatives as Gpr38 Agonists
    申请人:MacDonald Gregor James
    公开号:US20080312209A1
    公开(公告)日:2008-12-18
    The invention provides compounds of formula (I) or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Z, X and B are as defined in the specification. The compounds are partial or full agonists at the GPR38 receptor. Pharmaceutical compositions comprising the compounds, methods of preparing the compounds, uses of the compounds and methods involving the compounds are also provided.
    该发明提供了式(I)的化合物或其药学上可接受的盐, 其中R1、R2、R3、R4、R5、R6、Z、X和B如规范中所定义。这些化合物是GPR38受体的部分或全激动剂。还提供了包括这些化合物的药物组合物、制备这些化合物的方法、这些化合物的用途以及涉及这些化合物的方法。
  • [EN] FACTOR XIIa INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR XIIA
    申请人:MERCK SHARP & DOHME
    公开号:WO2018093695A1
    公开(公告)日:2018-05-24
    The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIIa inhibitors.
    本发明提供了一种化合物(I)及包含一种或多种所述化合物的药物组合物,以及使用所述化合物治疗或预防血栓、栓塞、高凝状态或纤维化变化的方法。这些化合物是选择性凝血因子XIIa抑制剂。
  • [EN] SHP2 INHIBITORS<br/>[FR] INHIBITEURS DE SHP2
    申请人:IRBM S P A
    公开号:WO2021028362A1
    公开(公告)日:2021-02-18
    The present invention relates to new compounds capable of inhibiting the activity of SHP2 phosphatase, having the general Formula (I).
    本发明涉及一种能够抑制SHP2磷酸酶活性的新化合物,其具有一般式(I)。
  • [EN] ADAMANTYL DERIVATES AS P2X7 RECEPTOR ANTAGONISTS<br/>[FR] DERIVES D'ADAMANTYL UTILISES COMME ANTAGONISTES DU RECEPTEUR P2X7
    申请人:ASTRAZENECA AB
    公开号:WO2006025783A1
    公开(公告)日:2006-03-09
    The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
    这项发明提供了公式(I)化合物及其药用可接受盐或溶剂化物,其中R1、A1、m和A如规范中定义;它们的制备方法;含有它们的药物组合物;以及它们在治疗中的应用。
  • Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide
    作者:Sergey Vshyvenko、Mary Rose Reisenauer、Snezna Rogelj、Tomas Hudlicky
    DOI:10.1016/j.bmcl.2014.07.034
    日期:2014.9
    Several unnatural derivatives of narciclasine were prepared in which the C-7 carbon was replaced with nitrogen. The 7-aza derivative and its N-oxide were prepared by the coupling of iodopicolinic acid with a conduramine unit derived chemoenzymatically from bromobenzene. Intramolecular Heck reaction was used to construct the isocarbostyryl ring system. The compounds were submitted to biological screening
    制备了水仙环素的几种非天然衍生物,其中 C-7 碳被氮取代。7-氮杂衍生物及其N-氧化物是通过碘吡啶甲酸与化学酶法衍生自溴苯的康杜明单元偶联而制备的。采用分子内 Heck 反应构建异喹诺酮环体系。这些化合物被用于针对癌细胞系的生物筛选。为所有新化合物提供完整的实验和光谱数据。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-